FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156044304> ?p ?o ?g. }

• W2156044304 endingPage "428" @default.
• W2156044304 startingPage "421" @default.
• W2156044304 abstract "Background Attention Deficit Hyperactivity Disorder (ADHD) is the most common co-morbid condition encountered in people with tics and Tourette Syndrome (TS). The co-occurrence of TS and ADHD is associated with a higher psychopathological, social and academic impairment and the management may represent a challenge for the clinicians. Aim To review recent advances in management of patients with tic, Tourette Syndrome and comorbid Attention Deficit Hyperactivity Disorder. Methods We searched peer reviewed and original medical publications (PUBMED 1990–2012) and included randomized, double-blind, controlled trials related to pharmacological treatment for tic and TS used in children and adolescents with comorbid ADHD. “Tourette Syndrome” or “Tic” and “ADHD”, were cross referenced with the words “pharmacological treatment”, “α-agonist”, “psychostimulants”, “selective norepinephrine reuptake inhibitor”, “antipsychotics”. Results Three classes of drugs are currently used in the treatment of TS and comorbid ADHD: α-agonists (clonidine and guanfacine), stimulants (amphetamine enantiomers, methylphenidate enantiomers or slow release preparation), and selective norepinephrine reuptake inhibitor (atomoxetine). It has been recently suggested that in a few selected cases partial dopamine agonists (aripiprazole) could be useful. Conclusion Level A of evidence supported the use of noradrenergic agents (clonidine). Reuptake inhibitors (atomoxetine) and stimulants (methylphenidate) could be, also used for the treatment of TS and comorbid ADHD. Taking into account the risk–benefit profile, clonidine could be used as the first line treatment. However only few studies meet rigorous quality criteria in terms of study design and methodology; most trials have low statistical power due to small sample size or short duration. Treatment should be “symptom targeted” and personalized for each patient." @default.
• W2156044304 created "2016-06-24" @default.
• W2156044304 creator A5003553304 @default.
• W2156044304 creator A5004414249 @default.
• W2156044304 creator A5074767492 @default.
• W2156044304 creator A5076191754 @default.
• W2156044304 date "2013-09-01" @default.
• W2156044304 modified "2023-10-01" @default.
• W2156044304 title "Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options" @default.
• W2156044304 cites W1519906268 @default.
• W2156044304 cites W1550610883 @default.
• W2156044304 cites W1872091818 @default.
• W2156044304 cites W189522227 @default.
• W2156044304 cites W1963644974 @default.
• W2156044304 cites W1975785302 @default.
• W2156044304 cites W197882156 @default.
• W2156044304 cites W1982522250 @default.
• W2156044304 cites W1995484354 @default.
• W2156044304 cites W1997290932 @default.
• W2156044304 cites W1998247306 @default.
• W2156044304 cites W2001006163 @default.
• W2156044304 cites W2002149980 @default.
• W2156044304 cites W2006473535 @default.
• W2156044304 cites W2006624153 @default.
• W2156044304 cites W2008455052 @default.
• W2156044304 cites W2008627947 @default.
• W2156044304 cites W2010611267 @default.
• W2156044304 cites W2010947265 @default.
• W2156044304 cites W2015209979 @default.
• W2156044304 cites W2015540486 @default.
• W2156044304 cites W2031959540 @default.
• W2156044304 cites W2033671805 @default.
• W2156044304 cites W2033679013 @default.
• W2156044304 cites W2033904073 @default.
• W2156044304 cites W2043525100 @default.
• W2156044304 cites W2044466939 @default.
• W2156044304 cites W2048586129 @default.
• W2156044304 cites W2052257123 @default.
• W2156044304 cites W2054694711 @default.
• W2156044304 cites W2061984230 @default.
• W2156044304 cites W2069907474 @default.
• W2156044304 cites W2078752612 @default.
• W2156044304 cites W2087040765 @default.
• W2156044304 cites W2090412275 @default.
• W2156044304 cites W2092202774 @default.
• W2156044304 cites W2107612326 @default.
• W2156044304 cites W2109413825 @default.
• W2156044304 cites W2109789351 @default.
• W2156044304 cites W2112506842 @default.
• W2156044304 cites W2114409847 @default.
• W2156044304 cites W2128074636 @default.
• W2156044304 cites W2136277713 @default.
• W2156044304 cites W2144212416 @default.
• W2156044304 cites W2144501335 @default.
• W2156044304 cites W2150855904 @default.
• W2156044304 cites W2159419408 @default.
• W2156044304 cites W2164549762 @default.
• W2156044304 cites W2169757912 @default.
• W2156044304 cites W2171208117 @default.
• W2156044304 cites W2266471137 @default.
• W2156044304 doi "https://doi.org/10.1016/j.ejpn.2013.01.005" @default.
• W2156044304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23473832" @default.
• W2156044304 hasPublicationYear "2013" @default.
• W2156044304 type Work @default.
• W2156044304 sameAs 2156044304 @default.
• W2156044304 citedByCount "65" @default.
• W2156044304 countsByYear W21560443042013 @default.
• W2156044304 countsByYear W21560443042014 @default.
• W2156044304 countsByYear W21560443042015 @default.
• W2156044304 countsByYear W21560443042016 @default.
• W2156044304 countsByYear W21560443042017 @default.
• W2156044304 countsByYear W21560443042018 @default.
• W2156044304 countsByYear W21560443042019 @default.
• W2156044304 countsByYear W21560443042020 @default.
• W2156044304 countsByYear W21560443042021 @default.
• W2156044304 countsByYear W21560443042022 @default.
• W2156044304 countsByYear W21560443042023 @default.
• W2156044304 crossrefType "journal-article" @default.
• W2156044304 hasAuthorship W2156044304A5003553304 @default.
• W2156044304 hasAuthorship W2156044304A5004414249 @default.
• W2156044304 hasAuthorship W2156044304A5074767492 @default.
• W2156044304 hasAuthorship W2156044304A5076191754 @default.
• W2156044304 hasConcept C118552586 @default.
• W2156044304 hasConcept C15744967 @default.
• W2156044304 hasConcept C2776412080 @default.
• W2156044304 hasConcept C2777026814 @default.
• W2156044304 hasConcept C2777112843 @default.
• W2156044304 hasConcept C2777200579 @default.
• W2156044304 hasConcept C2778399450 @default.
• W2156044304 hasConcept C2778781522 @default.
• W2156044304 hasConcept C2780211496 @default.
• W2156044304 hasConcept C2780783007 @default.
• W2156044304 hasConcept C2780815205 @default.
• W2156044304 hasConcept C42219234 @default.
• W2156044304 hasConcept C71924100 @default.
• W2156044304 hasConceptScore W2156044304C118552586 @default.
• W2156044304 hasConceptScore W2156044304C15744967 @default.
• W2156044304 hasConceptScore W2156044304C2776412080 @default.

• next